本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Estrella Immunopharma

0.7353
-0.0097-1.30%
盤後0.73530.00000.00%19:15 EDT
成交量:8,186
成交額:6,095.42
市值:3,198.40萬
市盈率:-2.90
高:0.7605
開:0.7605
低:0.7206
收:0.7450
52周最高:3.15
52周最低:0.6781
股本:4,349.79萬
流通股本:1,457.37萬
量比:0.19
換手率:0.06%
股息:- -
股息率:- -
每股收益(TTM):-0.2536
每股收益(LYR):-0.3548
淨資產收益率:-268.50%
總資產收益率:-251.86%
市淨率:-4.30
市盈率(LYR):-2.07

資料載入中...

2026/08/21

重要事件披露

Form 8-K - Current report
2026/08/14

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/08/13

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/06/30

重要事件披露

Form 8-K - Current report
2026/05/16

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/05/15

超過5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/04/30

[修訂]年度報告

Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
2026/03/18

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2026/01/23

SEC問詢函

Form CORRESP - Correspondence
2026/01/22

[修訂]招股説明書

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2026/01/16

[修訂]招股説明書

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2026/01/13

重要事件披露

Form 8-K - Current report
2026/01/07

重要事件披露

Form 8-K - Current report
2025/12/22

招股説明書

Form S-1 - General form for registration of securities under the Securities Act of 1933
2025/12/04

重要事件披露

Form 8-K - Current report
2025/11/12

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/11/06

重要事件披露

Form 8-K - Current report
2025/09/29

重要事件披露

Form 8-K - Current report
2025/09/26

重要事件披露

Form 8-K - Current report
2025/08/12

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]